Medical News Summary: Drug approved for treatment of diabetic peripheral neuropathy
About: Drug approved for treatment of diabetic peripheral neuropathy
Date: 21 October 2004
Source: Onlypunjab
Medical News Summary (summary of medical news story as reported by Onlypunjab): Cymbalta has been recently approved by the FDA for use in pain management for sufferers of diabetic peripheral neuropathy. 62% of diabetic patients will develop this condition and is associated with sensations of burning, tingling and numbness. Clinical trials of the product have shown significant pain relief in many and the main side effects were nausea, dry mouth, constipation, diarrhea, dizziness and hot flashes.
URL: http://www.onlypunjab.com/real/fullstory-newsID-8701.html
Related Disease Topics: Diabetes, Peripheral neuropathy
Related Symptom Topics: Nausea, dry mouth, constipation, diarrhea, dizziness, hot flashes, burning, tingling and numbness
Related Medical News Channels: This medical news summary article refers to the following medical channel categories:
- Autoimmune disease
- Medication
- medication and diabetes
- medication and peripheral neuropathy
- medication and hot flashes
- medication and burning
- medication and tingling
- medication and numbness
- medication and nausea
- medication and dry mouth
- medication and constipation
- medication and diarrhea
- medication and dizziness
Medical Tools & Articles:
Next articles:
Medical Articles: